Optic Neuropathies : : Current and Future Strategies for Optic Nerve Protection and Repair / / Rongkung Tsai, Neil R. Miller, editors.

Optic neuropathies are conditions in which there is damage to the optic nerve (ON) caused by a variety of causes, including glaucoma, inflammation, gene abnormalities, ischemia, trauma, and toxicity. ON damage triggers a process of axon degeneration, inflammatory cytokine upregulation, breakdown of...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023.
Year of Publication:2023
Language:English
Physical Description:1 online resource (322 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993607574604498
ctrlnum (CKB)4960000000468864
(NjHacI)994960000000468864
(EXLCZ)994960000000468864
collection bib_alma
record_format marc
spelling Optic Neuropathies : Current and Future Strategies for Optic Nerve Protection and Repair / Rongkung Tsai, Neil R. Miller, editors.
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2023.
1 online resource (322 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Optic neuropathies are conditions in which there is damage to the optic nerve (ON) caused by a variety of causes, including glaucoma, inflammation, gene abnormalities, ischemia, trauma, and toxicity. ON damage triggers a process of axon degeneration, inflammatory cytokine upregulation, breakdown of the blood-optic nerve barrier, and, eventually, the induction of apoptosis of retinal ganglion cells (RGCs), resulting in optic atrophy. To date, there is no effective treatment for most optic neuropathies; however, because the damage initially is axogenic, there may exist a window of therapeutic opportunity before the death of RGCs. Thus, the search for effective treatments for various optic neuropathies before there is permanent damage to prevent or limit visual dysfunction and the development of methods to stimulate axon and/or RGC regeneration to restore vision after damage has occurred is pivotal.This reprint collected 19 articles published in this Special Issue of IJMS which covers the molecular mechanisms to protect RGCs and/or axonal damage, translational research, gene therapy, regenerative medicine, and neuroprotection for glaucoma.
Medicine.
Medicine, Chinese Popular works.
3-0365-7504-9
Miller, Neil R., editor.
Tsai, Rongkung, editor.
language English
format eBook
author2 Miller, Neil R.,
Tsai, Rongkung,
author_facet Miller, Neil R.,
Tsai, Rongkung,
author2_variant n r m nr nrm
r t rt
author2_role TeilnehmendeR
TeilnehmendeR
title Optic Neuropathies : Current and Future Strategies for Optic Nerve Protection and Repair /
spellingShingle Optic Neuropathies : Current and Future Strategies for Optic Nerve Protection and Repair /
title_sub Current and Future Strategies for Optic Nerve Protection and Repair /
title_full Optic Neuropathies : Current and Future Strategies for Optic Nerve Protection and Repair / Rongkung Tsai, Neil R. Miller, editors.
title_fullStr Optic Neuropathies : Current and Future Strategies for Optic Nerve Protection and Repair / Rongkung Tsai, Neil R. Miller, editors.
title_full_unstemmed Optic Neuropathies : Current and Future Strategies for Optic Nerve Protection and Repair / Rongkung Tsai, Neil R. Miller, editors.
title_auth Optic Neuropathies : Current and Future Strategies for Optic Nerve Protection and Repair /
title_new Optic Neuropathies :
title_sort optic neuropathies : current and future strategies for optic nerve protection and repair /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2023
physical 1 online resource (322 pages)
isbn 3-0365-7504-9
callnumber-first R - Medicine
callnumber-subject R - General Medicine
callnumber-label R129
callnumber-sort R 3129 O685 42023
genre_facet Popular works.
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 610 - Medicine & health
dewey-full 610.951
dewey-sort 3610.951
dewey-raw 610.951
dewey-search 610.951
work_keys_str_mv AT millerneilr opticneuropathiescurrentandfuturestrategiesforopticnerveprotectionandrepair
AT tsairongkung opticneuropathiescurrentandfuturestrategiesforopticnerveprotectionandrepair
status_str n
ids_txt_mv (CKB)4960000000468864
(NjHacI)994960000000468864
(EXLCZ)994960000000468864
carrierType_str_mv cr
is_hierarchy_title Optic Neuropathies : Current and Future Strategies for Optic Nerve Protection and Repair /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1796653275760558080
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02206nam a2200301 i 4500</leader><controlfield tag="001">993607574604498</controlfield><controlfield tag="005">20230730225855.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230730s2023 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4960000000468864</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994960000000468864</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994960000000468864</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R129</subfield><subfield code="b">.O685 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610.951</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Optic Neuropathies :</subfield><subfield code="b">Current and Future Strategies for Optic Nerve Protection and Repair /</subfield><subfield code="c">Rongkung Tsai, Neil R. Miller, editors.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (322 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Optic neuropathies are conditions in which there is damage to the optic nerve (ON) caused by a variety of causes, including glaucoma, inflammation, gene abnormalities, ischemia, trauma, and toxicity. ON damage triggers a process of axon degeneration, inflammatory cytokine upregulation, breakdown of the blood-optic nerve barrier, and, eventually, the induction of apoptosis of retinal ganglion cells (RGCs), resulting in optic atrophy. To date, there is no effective treatment for most optic neuropathies; however, because the damage initially is axogenic, there may exist a window of therapeutic opportunity before the death of RGCs. Thus, the search for effective treatments for various optic neuropathies before there is permanent damage to prevent or limit visual dysfunction and the development of methods to stimulate axon and/or RGC regeneration to restore vision after damage has occurred is pivotal.This reprint collected 19 articles published in this Special Issue of IJMS which covers the molecular mechanisms to protect RGCs and/or axonal damage, translational research, gene therapy, regenerative medicine, and neuroprotection for glaucoma.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine, Chinese</subfield><subfield code="v">Popular works.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-7504-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miller, Neil R.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsai, Rongkung,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-05 08:48:37 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-07-01 21:33:43 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5346552170004498&amp;Force_direct=true</subfield><subfield code="Z">5346552170004498</subfield><subfield code="b">Available</subfield><subfield code="8">5346552170004498</subfield></datafield></record></collection>